The First AI Drug Prescriber

Document Type

Article

Publication Date

4-13-2026

ISSN

0098-7484

Publisher

JAMA Network

Language

en-US

Abstract

In January 2026, Utah announced a first-of-its-kind partnership with an artificial intelligence (AI) company to prescribe medications without physician involvement. The system, sold by Doctronic, is designed to conduct a “comprehensive medical assessment” that “mirrors the clinical decision-making process a licensed physician would follow.”1 Initially focusing on prescription renewals, the software is slated to prescribe almost 200 drugs, including corticosteroids, statins, antidepressants, hormones, and anticlotting agents. This Viewpoint explores this pathbreaking entry of AI into clinical care, the role of the US Food and Drug Administration (FDA), and the associated legal, public health, and medical implications.

This document is currently not available here.

Link to Publisher Site Link to Publisher Site (BU Community Subscription)

Share

COinS